title: An overview of low disease activity and remission in psoriatic arthritis.
abstract: Psoriatic arthritis (PsA) is a complex, multisystem and potentially disabling disease with musculoskeletal and skin manifestations. In PsA, as well as in the other chronic rheumatic conditions, a state of low disease activity or remission should be the target of treatment but to reach this objective, in the assessment of PsA patients, is still an unmet need due to the heterogeneity of disease manifestations. With the introduction of anti-TNF treatment, low disease activity or remission become an achievable and suitable state that could be reached by 50%-60% of PsA patients. The aim of this paper is to briefly summarise the concept of low disease activity and remission in PsA, with particular focus on anti-TNF therapy.
authors.affiliation: Academic Rheumatology Unit, Department of Medicine and Health Science "Vincenzo Tiberio", University of Molise, Italy. enniolubrano@hotmail.com.
authors.forename: Ennio
authors.initials: E
authors.lastname: Lubrano
authors.affiliation: Academic Rheumatology Unit, Department of Medicine and Health Science "Vincenzo Tiberio", University of Molise, Italy.
authors.forename: Fabio Massimo
authors.initials: FM
authors.lastname: Perrotta
authors.affiliation: Division of Rheumatology, Allergy, and Immunology Center for Innovative Therapy (CIT), University of California, San Diego, La Jolla, CA, USA.
authors.forename: Arthur
authors.initials: A
authors.lastname: Kavanaugh
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000175:diagnosis* / Q000188:drug therapy* / Q000276:immunology; D001688:Biological Products / Q000627:therapeutic use*; D023381:Endpoint Determination; D006304:Health Status; D006305:Health Status Indicators; D006801:Humans; D011237:Predictive Value of Tests; D012074:Remission Induction; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology
chemical_list: D000893:Anti-Inflammatory Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha